Filing metadata

Accession number
0001127602-23-001498
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jan 17, 2023
Reporting period
Apr 25, 2022
Description
Insider transaction

Explore SEC Filings Hub